compound glp-1 fda Pharmacovigilance Assessment of Compounded Receptor Agonists: Insights From the Adverse Event Reporting System FDA Updates on Compounded GLP-1

& Ling, C

Facts GLP-1 medications have gained widespread attention, but there is also significant misinformation surrounding these treatments

Risks Medications in the GLP-1 family have caused thyroid tumors in lab mice

Learn more about tracking tirzepatide injections or see our Mounjaro progress tracking guide

The most common side effects are: Nausea Vomiting Constipation Mild diarrhea Indigestion These are usually temporary and improve with gradual dose escalation

In consideration of JMs desire for a once-weekly product and a desire to add an agent with proven cardiovascular benefit and notable weight loss, injectable semaglutide was selected and initiated